Board Meeting4 Aug 2026, 10:36 am
AstraZeneca India Board Meeting on Aug 10 to Approve Q2 2026 Results
AI Summary
AstraZeneca Pharma India Ltd has announced that its Board of Directors will convene on August 10, 2026. The primary agenda item for this meeting is to consider and approve the un-audited financial results for the quarter ended June 30, 2026. Additionally, the company confirmed that the trading window for designated persons will remain closed from June 16, 2026, to August 12, 2026, inclusive, in compliance with SEBI regulations on insider trading.
Key Highlights
- Board meeting scheduled for August 10, 2026.
- Agenda includes approval of Q2 2026 un-audited financial results.
- Trading window closure in effect until August 12, 2026.
- Compliance with SEBI Insider Trading Regulations confirmed.
Price Impact
More from ASTRAZEN